At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Nov 11, 2026 at 16:05 ET
iRhythm's board authorized a $200 million share repurchase program, signaling confidence in the core business and the recently acquired VitalConnect. The buyback is discretionary and may be modified or suspended at any time.
- Board approved up to $200 million in share repurchases on November 10, 2026
- Repurchases may be made in open market, privately negotiated, or accelerated share repurchase transactions
- Program may be modified, suspended, or terminated at any time at the Board's discretion
- Funding expected from existing cash, cash equivalents, and ongoing operations
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access